1. Home
  2. APLT vs MQY Comparison

APLT vs MQY Comparison

Compare APLT & MQY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLT
  • MQY
  • Stock Information
  • Founded
  • APLT 2016
  • MQY 1994
  • Country
  • APLT United States
  • MQY United States
  • Employees
  • APLT N/A
  • MQY N/A
  • Industry
  • APLT Biotechnology: Pharmaceutical Preparations
  • MQY Investment Bankers/Brokers/Service
  • Sector
  • APLT Health Care
  • MQY Finance
  • Exchange
  • APLT Nasdaq
  • MQY Nasdaq
  • Market Cap
  • APLT 971.6M
  • MQY 892.2M
  • IPO Year
  • APLT 2019
  • MQY N/A
  • Fundamental
  • Price
  • APLT $9.09
  • MQY $12.46
  • Analyst Decision
  • APLT Strong Buy
  • MQY
  • Analyst Count
  • APLT 5
  • MQY 0
  • Target Price
  • APLT $12.50
  • MQY N/A
  • AVG Volume (30 Days)
  • APLT 1.6M
  • MQY 184.8K
  • Earning Date
  • APLT 11-15-2024
  • MQY 01-01-0001
  • Dividend Yield
  • APLT N/A
  • MQY 4.73%
  • EPS Growth
  • APLT N/A
  • MQY N/A
  • EPS
  • APLT N/A
  • MQY N/A
  • Revenue
  • APLT N/A
  • MQY N/A
  • Revenue This Year
  • APLT N/A
  • MQY N/A
  • Revenue Next Year
  • APLT $3,358.27
  • MQY N/A
  • P/E Ratio
  • APLT N/A
  • MQY N/A
  • Revenue Growth
  • APLT N/A
  • MQY N/A
  • 52 Week Low
  • APLT $1.79
  • MQY $9.82
  • 52 Week High
  • APLT $9.39
  • MQY $12.52
  • Technical
  • Relative Strength Index (RSI)
  • APLT 61.27
  • MQY 31.85
  • Support Level
  • APLT $8.38
  • MQY $12.32
  • Resistance Level
  • APLT $9.29
  • MQY $13.07
  • Average True Range (ATR)
  • APLT 0.55
  • MQY 0.13
  • MACD
  • APLT -0.06
  • MQY -0.05
  • Stochastic Oscillator
  • APLT 76.93
  • MQY 18.00

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

About MQY Blackrock MuniYield Quality Fund Inc.

Blackrock Muniyield Quality Fund Inc is a closed-end management investment company. The company's objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes as is consistent with its investment policies and prudent investment management. The company invests in Transportation, Corporate, Health, Utilities, Education, Housing, and other sectors.

Share on Social Networks: